Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FDPS | P14324 | 10/20 | 0.48 |
| ▸ | GGPS1 | O95749 | 7/20 | 0.48 |
| ▸ | TSHR | P16473 | 1/20 | 0.44 |
| ▸ | THRB | P10828 | 1/20 | 0.44 |
| ▸ | SMPD1 | P17405 | 1/20 | 0.43 |
| ▸ | CES2 | O00748 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27558073 | 1.00 | FDPS (0.48) | FDPSGGPS1TSHRTHRBSMPD1 | |
| SCHEMBL30787209 | 1.00 | FDPS (0.48) | FDPSGGPS1TSHRTHRBSMPD1 | |
| SCHEMBL728012 | 1.00 | FDPS (0.48) | FDPSGGPS1TSHRTHRBSMPD1 | |
| SCHEMBL27565316 | 1.00 | FDPS (0.48) | FDPSGGPS1TSHRTHRBSMPD1 | |
| SCHEMBL999089 | 1.00 | FDPS (0.48) | FDPSGGPS1TSHRTHRBSMPD1 | |
| SCHEMBL30787208 | 1.00 | FDPS (0.48) | FDPSGGPS1TSHRTHRBSMPD1 | |
| SCHEMBL30787223 | 1.00 | FDPS (0.48) | FDPSGGPS1TSHRTHRBSMPD1 | |
| SCHEMBL30787174 | 1.00 | FDPS (0.48) | FDPSGGPS1TSHRTHRBSMPD1 | |
| SCHEMBL28791850 | 1.00 | FDPS (0.48) | FDPSGGPS1TSHRTHRBSMPD1 | |
| SCHEMBL14660128 | 1.00 | FDPS (0.48) | FDPSGGPS1TSHRTHRBSMPD1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3868740-B1 | CARBOXYLIC ACID-TYPE LIPID, AND LIPID PARTICLE AND LIPID MEMBRANE CONTAINING CARBOXYLIC ACID-TYPE LIPID | TORAY INDUSTRIES (JP) | 2025-08-06 | — | — | EP | disclosed |
| US-20250205384-A1 | HEMOSTATIC MATERIAL | TORAY INDUSTRIES, INC. (JP) | 2025-06-26 | — | — | US | disclosed |
| US-12325677-B2 | Carboxylic acid-type lipid, and lipid particle and lipid membrane each comprising carboxylic acid-type lipid | TORAY INDUSTRIES, INC. (JP) | 2025-06-10 | — | — | US | disclosed |
| EP-4554379-A1 | USE OF AN ALKANEDIOL AS HERBICIDE | Apeo - Agronomical Plant Extracts & Essential Oils (BE) | 2025-05-21 | — | — | EP | disclosed |
| US-12297302-B2 | Amphiphilic compound, and medical resin composition and pharmaceutical additive using the same | NIPPON SHOKUBAI CO., LTD. (JP) | 2025-05-13 | — | — | US | disclosed |
| WO-2025022920-A1 | LIPID NANOPARTICLES | 株式会社日本触媒 | 2025-01-30 | — | — | WO | disclosed |
| US-20240342195-A1 | AGENT FOR COMBINATION USE COMPRISING T CELL AND/OR B CELL ACTIVITY REGULATOR | TOKAI UNIVERSITY EDUCATIONAL SYSTEM (JP) | 2024-10-17 | — | — | US | disclosed |
| EP-3868413-B1 | HEMOSTATIC MATERIAL | TORAY INDUSTRIES (JP) | 2024-07-24 | — | — | EP | disclosed |
| EP-4382107-A1 | COMPANION DRUG COMPRISING ACTIVITY REGULATOR FOR T CELL AND/OR B CELL | Tokai University Educational System (JP) | 2024-06-12 | — | — | EP | disclosed |
| WO-2024013148-A1 | USE OF AN ALKANEDIOL AS HERBICIDE | APEO – AGRONOMICAL PLANT EXTRACTS & ESSENTIAL OILS (BE) | 2024-01-18 | — | — | WO | disclosed |
| US-20220185918-A1 | AMPHIPHILIC COMPOUND, AND MEDICAL RESIN COMPOSITION AND PHARMACEUTICAL ADDITIVE USING THE SAME | NIPPON SHOKUBAI CO., LTD. (JP) | 2022-06-16 | — | — | US | disclosed |
| US-20220096707-A1 | HEMOSTATIC MATERIAL | TORAY INDUSTRIES, INC. (JP) | 2022-03-31 | — | — | US | disclosed |
| EP-3950735-A1 | AMPHIPHILIC COMPOUND, AND RESIN COMPOSITION FOR MEDICAL USE AND DRUG ADDITIVE EACH USING SAME | Nippon Shokubai Co., Ltd. (JP) | 2022-02-09 | — | — | EP | disclosed |
| WO-2013016133-A2 | A ONE-COMPONENT, DUAL-CURE ADHESIVE FOR USE ON ELECTRONICS | H.B. FULLER COMPANY (US) | 2013-01-31 | — | — | WO | disclosed |
| US-20120264955-A1 | SYSTEMS AND METHODS FOR PRODUCING SURFACTANTS AND SURFACTANT INTERMEDIATES | SARTEC CORPORATION (US) | 2012-10-18 | — | — | US | disclosed |
| WO-2012142494-A1 | SYSTEMS AND METHODS FOR PRODUCING SURFACTANTS AND SURFACTANT INTERMEDIATES | SARTEC CORPORATION (US) | 2012-10-18 | — | — | WO | disclosed |
| US-7968607-B2 | Cosmetics 1-isostearylglycerol-3-Sulfate Sodium Salt, used for constriction of keratinocytes; aging resistance | KOA CORPORATION (JP) | 2011-06-28 | — | — | US | disclosed |
| US-20080234390-A1 | SKIN PORE MINIMIZERS AND SKIN ELASTICITY IMPROVERS | KAO CORPORATION (JP) | 2008-09-25 | — | — | US | disclosed |
| US-20040009140-A1 | Skin pore minimizers and skin elasticity improvers | KAO CORPORATION (JP) | 2004-01-15 | — | — | US | disclosed |
| EP-1325737-A1 | SKIN PORE MINIMIZERS AND SKIN ELASTICITY IMPROVERS | Kao Corporation (JP) | 2003-07-09 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250205384-A1 | HEMOSTATIC MATERIAL | F2, F12, FGB | FDPS 3200/4885GGPS1 2080/4885TSHR 1262/4885 |
| US-20220185918-A1 | AMPHIPHILIC COMPOUND, AND MEDICAL RESIN COMPOSITION AND PHARMACEUTICAL ADDITIVE USING THE SAME | LIPA, ABHD16A, ABCB11 | FDPS 3582/4885GGPS1 2402/4885TSHR 3598/4885 |
| US-12297302-B2 | Amphiphilic compound, and medical resin composition and pharmaceutical additive using the same | LIPA, ABHD16A, ABCB11 | FDPS 3582/4885GGPS1 2402/4885TSHR 3598/4885 |
| US-20040009140-A1 | Skin pore minimizers and skin elasticity improvers | CUTA, DSG1, OGA | FDPS 4666/4885GGPS1 3007/4885TSHR 2176/4885 |
| US-12325677-B2 | Carboxylic acid-type lipid, and lipid particle and lipid membrane each comprising carboxylic acid-type lipid | PLTP, F2, GP6 | FDPS 1892/4885GGPS1 716/4885TSHR 2377/4885 |
| US-20080234390-A1 | SKIN PORE MINIMIZERS AND SKIN ELASTICITY IMPROVERS | DSG1, CUTA, OGA | FDPS 4735/4885GGPS1 3882/4885TSHR 2091/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.